Status:
TERMINATED
Circulating Markers in Preterm Infants With Perinatal and Neonatal Inflammation
Lead Sponsor:
Per Torp Sangild
Collaborating Sponsors:
Baoan Maternal And Child Health Care Hospital, Shenzhen, China
Conditions:
Sepsis
Necrotizing Enterocolitis
Eligibility:
All Genders
1-1 years
Brief Summary
Circulating markers to diagnose complications (sepsis, necrotizing enterocolitis) in preterm infants are often inaccurate, partly due to the lack of comprehensive studies with temporal evaluation from...
Detailed Description
Preterm infants (10% incidence worldwide), especially those who do not receive sufficient mother's own milk, are susceptible to infectious diseases including sepsis and necrotizing enterocolitis. Infa...
Eligibility Criteria
Inclusion
- Preterm infants born before the complete 32 weeks of gestation
- Signed parental consent
Exclusion
- Major congenital anomalies or birth defects
Key Trial Info
Start Date :
September 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03320785
Start Date
September 1 2017
End Date
December 31 2021
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shenzheng Baoan Maternity and Child Healthcare Hospital (SBMCH)
Shenzhen, Guangdong, China, 518133